Results 131 to 140 of about 24,779 (184)

Pharmacodynamic Modeling of Cinacalcet in Secondary Hyperparathyroidism: Efficacy and Influencing Factors Analysis. [PDF]

J Endocr Soc
Wang Z, Wang Y, Han S, Chen P, Wu R, Fang C, Cheng J, Wu Y, Guo T, Wen X, Li L.   +10 more
europepmc   +1 more source

Preoperative assessment for the risk of Clavien-Dindo classification ≥ II grade complications after total parathyroidectomy without auto-transplantation in patients with secondary hyperparathyroidism. [PDF]

Front Endocrinol (Lausanne)
Ni Y, Xu L, Li Z, Li L, Yan S, Cheng G, Wang C, Tang Y.   +7 more
europepmc   +1 more source

Assessment of quality of life following subtotal parathyroidectomy in patients with secondary hyperparathyroidism resulting from end-stage renal disease: a single-center prospective study in Vietnam. [PDF]

BMC Nephrol
Hiep PH, Luong TN, Hung DQ, Ket TD, Ngoc NA, Truong VM, Duc PT, Huy TQ, Ho ND, Anh DT, Quyen DVT, Hung BV, Hung DT.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Secondary and Tertiary Hyperparathyroidism

Journal of Clinical Densitometry, 2013
We reviewed the etiology and management of secondary and tertiary hyperparathyroidism. Secondary hyperparathyroidism is characterized by an increase in parathyroid hormone (PTH) that is appropriate and in response to a stimulus, most commonly low serum calcium. In secondary hyperparathyroidism, the serum calcium is normal and the PTH level is elevated.
Sophie A Jamal
exaly   +3 more sources

Secondary Hyperparathyroidism

Otolaryngologic Clinics of North America
Secondary hyperparathyroidism (SHPT) does not initiate as a primary dysfunction of parathyroid glands resulting from an intrinsic defect or disease but is the physiologic response of parathyroids to metabolic changes elsewhere in the body occurring over time.
Palak Choksi, Krupa Doshi
openaire   +3 more sources

Mechanisms of secondary hyperparathyroidism

American Journal of Physiology-Renal Physiology, 2002
Small decreases in serum Ca2+and more prolonged increases in serum phosphate (Pi) stimulate the parathyroid (PT) to secrete parathyroid hormone (PTH), and 1,25(OH)2D3decreases PTH synthesis and secretion. A prolonged decrease in serum Ca2+and 1,25(OH)2D3, or increase in serum Pi, such as in patients with chronic renal failure, leads to the appropriate ...
Justin, Silver, Rachel, Kilav, Tally, Naveh-Many   +2 more
openaire   +2 more sources

Myelofibrosis Secondary to Hyperparathyroidism

Experimental and Clinical Endocrinology & Diabetes, 2004
We report on a young female who had presented with fatigue, bilateral knee pain and gait disturbance. Primary hyperparathyroidism was diagnosed together with splenomegaly and anemia. Bone marrow biopsy revealed myelofibrosis. A parathyroid adenoma was excised during surgical intervention.
B, Kumbasar, I, Taylan, R, Kazancioglu, M, Agan, M, Yenigun, F, Sar   +5 more
openaire   +2 more sources

Cimetidine in Secondary Hyperparathyroidism

Annals of Internal Medicine, 1982
Excerpt To the editor: After anecdotal reports on a decrease of immunoreactive paraphyroid hormone (PTH) levels due to the administration of cimetidine in primary hyperparathyroidism (1,2), therape...
J, Kovarik, H, Graf, W, Woloszczuk, H K, Stummvoll   +3 more
openaire   +2 more sources